New technology developed by researchers at the University of Houston could revolutionize medical imaging and lead to faster, ...

Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...

The MRI contrast agents market is expected to grow 1.3X from 2022 to 2029, reaching USD 1.23 Billion by 2029. Paramagnetic ...

The company has reported the first phase 3 results in hand for gadoquatrane, which reduces the dose of gadolinium delivered ...

New MRI scanning technology developed at Aberdeen University could improve cancer detection and reduce repeat surgeries by ...

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative ...

Sanochemia Pharmazeutika today announced positive headline results of the pivotal phase III study PROSTAPROGRESS on Ferumoxtran (EudraCT 2018-004310-18), performed by SPL Medical B.V. (Nijmegen, The ...

The AI model processes pre-contrast and a single post-contrast T1 image, identifying suspicious regions and assigning a ...

Emerging MRI techniques provide a radiation-free alternative to CT scans for diagnosing pulmonary and mediastinal diseases in ...

Ferumoxtran is an MRI Contrast Agent that may be used to detect lymph node metastases as small as 2 mm in prostate cancer patients. Sanochemia has secured exclusive global commercialization rights ...